CAS: 1070790-89-4
Ref: IN-DA01EOQ8
| 1mg | 49.00 € | ||
| 5mg | 102.00 € | ||
| 10mg | 181.00 € | ||
| 25mg | 199.00 € | ||
| 50mg | 336.00 € | ||
| 100mg | 537.00 € |
Estimated delivery in United States, on Monday 14 Apr 2025
(2R,3S)-3-((6-(((4,6-Dimethylpyridin-3-Yl)Methyl)Amino)-9-Isopropyl-9H-Purin-2-Yl)Amino)Pentan-2-Ol
CAS:1070790-89-4
Purity:
98%
Molecular weight:
397.52g/mol
Ref: 54-OR1023066
| 1g | 2,020.00 € | ||
| 100mg | 633.00 € | ||
| 250mg | 1,056.00 € |
Estimated delivery in United States, on Tuesday 15 Apr 2025
Ref: 54-BUP09133
| 25mg | 461.00 € | ||
| 50mg | 654.00 € | ||
| 100mg | 903.00 € | ||
| 200mg | 1,217.00 € |
Estimated delivery in United States, on Tuesday 15 Apr 2025
Fadraciclib
CAS:1070790-89-4
Fadraciclib (CYC065) is an orally available, second-generation ATP-competitive inhibitor of CDK2/CDK9 kinases (IC50s: 5/26 nM).
Formula:
C21H31N7O
Purity:
99.75%
Color and Shape:
Solid
Molecular weight:
397.52
Ref: TM-TQ0053
| 1mg | 48.00 € | ||
| 5mg | 101.00 € | ||
| 10mg | 178.00 € | ||
| 25mg | 304.00 € | ||
| 50mg | 437.00 € | ||
| 100mg | 615.00 € | ||
| 200mg | 830.00 € | ||
| 1mL*10mM (DMSO) | 111.00 € |
Estimated delivery in United States, on Monday 21 Apr 2025
CYC065
CAS:1070790-89-4
Inhibitor of CDK2/CDK9 kinases
Formula:
C21H31N7O
Purity:
Min. 95%
Molecular weight:
397.52 g/mol
Ref: 3D-BC175840
| 1mg | 511.00 € | ||
| 2mg | 730.00 € | ||
| 5mg | 1,304.00 € | ||
| 10mg | 1,956.00 € | ||
| 25mg | 3,175.00 € |
Estimated delivery in United States, on Tuesday 27 May 2025
